Nevan C. Elam

Companies

• Savara IncBoard member May 5, 2017 to now¹
• Rezolute, Inc.Board member Feb 8, 2013 to now²
• Rezolute, Inc.Chief executive officer Feb 8, 2013 to now²
• Peak Bio, Inc.Board member Nov 3, 2022 to Nov 3, 2022³
• Nektar TherapeuticsVP, Pulmonary Business Unit Apr 4, 2007 to Feb 27, 2008⁴
• Nektar TherapeuticsGeneral counsel Mar 13, 2006 to Sep 6, 2006⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• RRezolute, Inc. RZLT605,497 shares⁶$2.2M at $3.69Jul 2, 2026
• SSavara Inc SVRA106,887 shares⁷$502.4K at $4.70Dec 9, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 2, 2026Shares withheld for tax 8,004 shares at $4.99 of Rezolute, Inc.⁶
• Mar 2, 2026Shares withheld for tax 27,618 shares at $2.99 of Rezolute, Inc.⁸
• Dec 15, 2025Bought 32,000 shares at $1.59 of Rezolute, Inc.⁹
• Dec 9, 2025Granted 40,000 shares of Savara Inc⁷
• Dec 2, 2025Shares withheld for tax 1,473 shares at $5.81 of Savara Inc¹⁰
• Dec 2, 2025Exercised options 5,860 shares at $1.46 of Savara Inc¹⁰
• Nov 19, 2025Granted 317,000 shares of Rezolute, Inc.¹¹
• Jun 10, 2025Granted 68,000 shares of Rezolute, Inc.¹²
• Mar 27, 2025Bought 12,302 shares at $2.85 of Rezolute, Inc.¹³
• Feb 16, 2025Granted 204,000 shares of Rezolute, Inc.¹⁴
• Dec 12, 2024Granted 40,000 shares of Savara Inc¹⁵
• Feb 26, 2024Bought 5,000 shares at $1.68 of Rezolute, Inc.¹⁶
• Dec 28, 2023Sold 93,843 shares at $4.71 of Savara Inc¹⁷
• Dec 28, 2023Exercised options 40,000 shares at $1.23 of Savara Inc¹⁷
• Dec 28, 2023Exercised options 12,000 shares at $1.59 of Savara Inc¹⁷
• Dec 28, 2023Exercised options 1,758 shares at $0.82 of Savara Inc¹⁷
• Dec 14, 2023Granted 22,500 shares of Savara Inc¹⁸
• Dec 11, 2023Exercised options 10,841 shares at $0.82 of Savara Inc¹⁹
• Dec 13, 2022Exercised options 1,172 shares at $0.65 of Savara Inc²⁰
• Dec 6, 2021Exercised options 1,172 shares at $0.55 of Savara Inc²¹